Osara Health Publishes New Peer-Reviewed Study Demonstrating Clinically Meaningful Improvements in Physical and Mental Health for People With Cancer
Findings published in JMIR Cancer show measurable health gains for Osara Health participants, adding to a growing evidence base including a 25:1 independently validated return on investment. NEW YORK, April 15, 2026 /PRNewswire/ -- Osara Health, a...
Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.
Osara Health discloses its role as the primary cancer support provider in Swiss Re's independent Rehabilitation Watch 2025 report, which confirmed a 25:1 return on investment and the highest return-to-work rate of any condition at 71%. NEW YORK,...